Enanta Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:9EP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
06 Dec 24	Sell€39,219	Jay Luly	Individual	5,142	€7.63
06 Dec 24	Sell€17,413	Brendan Luu	Individual	2,283	€7.63
06 Dec 24	Sell€17,413	Tara Kieffer	Individual	2,283	€7.63
06 Dec 24	Sell€19,762	Paul Mellett	Individual	2,591	€7.63
06 Dec 24	Sell€19,762	Yat Or	Individual	2,591	€7.63
06 Dec 24	Sell€6,605	Scott Rottinghaus	Individual	866	€7.63

Insider Trading Volume

Insider Buying: 9EP insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9EP?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,344,366	5.93%
Hedge Funds	3,606,336	15.9%
Institutions	17,730,007	78.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 90.4% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.95%	Farallon Capital Management, L.L.C.	2,108,262	€10.6m	0.63%	0.07%
9.35%	The Vanguard Group, Inc.	1,981,866	€9.9m	2.45%	no data
8.97%	BlackRock, Inc.	1,900,323	€9.5m	2.86%	no data
7.07%	Krensavage Asset Management, LLC	1,498,074	€7.5m	19.7%	4.64%
4.72%	Armistice Capital LLC	1,000,000	€5.0m	-8.76%	0.13%
4.68%	Morgan Stanley, Investment Banking and Brokerage Investments	991,448	€5.0m	-25.6%	no data
4.01%	Marshall Wace LLP	850,890	€4.3m	-8.35%	0.01%
4.01%	Acadian Asset Management LLC	849,424	€4.3m	0%	0.01%
3.71%	Soleus Capital Management, L.P.	785,546	€3.9m	-1.75%	0.33%
3.6%	Jay Luly	763,713	€3.8m	2.67%	no data
3.45%	Millennium Management LLC	731,295	€3.7m	7.05%	no data
3.35%	Bank of America Corporation, Asset Management Arm	709,652	€3.6m	19.1%	no data
3.17%	Citadel Advisors LLC	672,880	€3.4m	44.6%	no data
2.53%	Northern Trust Global Investments	536,705	€2.7m	-36.5%	no data
2.48%	Renaissance Technologies LLC	524,900	€2.6m	2.74%	no data
2.37%	D. E. Shaw & Co., L.P.	501,372	€2.5m	-6.14%	no data
2.25%	Geode Capital Management, LLC	477,351	€2.4m	3.15%	no data
2.12%	State Street Global Advisors, Inc.	449,975	€2.3m	6.42%	no data
1.68%	Yat Or	356,909	€1.8m	1.32%	no data
1.55%	Columbia Management Investment Advisers, LLC	328,311	€1.6m	997%	no data
1.52%	Caligan Partners, LP	322,453	€1.6m	-69.1%	0.54%
1.1%	Two Sigma Advisers, LP	233,000	€1.2m	0.09%	no data
0.94%	UBS Asset Management AG	199,951	€1.0m	-3.83%	no data
0.92%	Dimensional Fund Advisors LP	194,460	€973.3k	50.7%	no data
0.9%	Jacobs Levy Equity Management Inc	191,726	€959.6k	-1.46%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/09 14:30
End of Day Share Price	2025/01/08 00:00
Earnings	2024/09/30
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enanta Pharmaceuticals, Inc. is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Brian Skorney	Baird
Geoffrey Meacham	Barclays
Patrick Trucchio	Berenberg